Heart Failure Reviews

, 14:155 | Cite as

OSA: the new cardiovascular disease

Part II: overview of cardiovascular diseases associated with obstructive sleep apnea
  • Kiran Devulapally
  • Raymond PongonisJr.
  • Rami Khayat


Obstructive sleep apnea (OSA), present in 5–15% of adults, is strongly associated with the incidence and poor outcome of hypertension, coronary artery disease, arrhythmia, heart failure, and stroke. Treatment of OSA completely reverses its cardiovascular consequences. In this review, we discuss the clinical evidence for the strong association between OSA and cardiovascular disease and present an argument for approaching OSA as a cardiovascular disease. We particularly focus on the causative relationship between OSA and hypertension, and on the increasingly recognized relationship between OSA and heart failure.


OSA Obstructive sleep apnea Sleep apnea Apnea Apneic episodes Sleep-disordered breathing CHF Congestive heart failure HTN Hypertension Stroke Pulmonary hypertension CAD Coronary artery disease Arrhythmia AHI Blood pressure 


  1. 1.
    Young T et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235. doi: 10.1056/NEJM199304293281704 PubMedGoogle Scholar
  2. 2.
    Center for Disease Control and Prevention. N.C.f.h.S., Health, U.D.o.H.a.H. Services, Editor (2006) National Health Interview Survey: US CensusGoogle Scholar
  3. 3.
    Marin JM et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053PubMedGoogle Scholar
  4. 4.
    Peppard PE et al (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384. doi: 10.1056/NEJM200005113421901 PubMedGoogle Scholar
  5. 5.
    Young T et al (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157(15):1746–1752. doi: 10.1001/archinte.157.15.1746 PubMedGoogle Scholar
  6. 6.
    Wilcox I et al (1993) Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 16(6):539–544PubMedGoogle Scholar
  7. 7.
    Becker HF et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73. doi: 10.1161/01.CIR.0000042706.47107.7A PubMedGoogle Scholar
  8. 8.
    Peker Y, Carlson J, Hedner J (2006) Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 28(3):596–602. doi: 10.1183/09031936.06.00107805 PubMedGoogle Scholar
  9. 9.
    Gami AS et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110(4):364–367. doi: 10.1161/01.CIR.0000136587.68725.8E PubMedGoogle Scholar
  10. 10.
    Kanagala R et al (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107(20):2589–2594PubMedGoogle Scholar
  11. 11.
    Reichmuth KJ et al (2005) Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172(12):1590–1595. doi: 10.1164/rccm.200504-637OC PubMedGoogle Scholar
  12. 12.
    Alchanatis M et al (2002) Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 20(5):1239–1245. doi: 10.1183/09031936.02.00278002 PubMedGoogle Scholar
  13. 13.
    Amin RS et al (2002) Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165(10):1395–1399. doi: 10.1164/rccm.2105118 PubMedGoogle Scholar
  14. 14.
    Wang H et al (2007) Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49(15):1625–1631. doi: 10.1016/j.jacc.2006.12.046 PubMedGoogle Scholar
  15. 15.
    Kaneko Y et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241PubMedGoogle Scholar
  16. 16.
    McNicholas WT, Bonsigore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156–178. doi: 10.1183/09031936.00027406 PubMedGoogle Scholar
  17. 17.
    Campos-Rodriguez F et al (2005) Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 128(2):624–633. doi: 10.1378/chest.128.2.624 PubMedGoogle Scholar
  18. 18.
    Doherty LS et al (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127(6):2076–2084. doi: 10.1378/chest.127.6.2076 PubMedGoogle Scholar
  19. 19.
    Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290(2):199–206. doi: 10.1001/jama.290.2.199 PubMedGoogle Scholar
  20. 20.
    Fields LE et al (2004) The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44(4):398–404. doi: 10.1161/01.HYP.0000142248.54761.56 PubMedGoogle Scholar
  21. 21.
    World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization, 2002.
  22. 22.
    Young T, Skatrud J, Peppard PE (2004) Risk factors for obstructive sleep apnea in adults. JAMA 291(16):2013–2016. doi: 10.1001/jama.291.16.2013 PubMedGoogle Scholar
  23. 23.
    Peker Y et al (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166(2):159–165. doi: 10.1164/rccm.2105124 PubMedGoogle Scholar
  24. 24.
    Silverberg DS, Oksenberg A (2001) Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Curr Hypertens Rep 3(3):209–215. doi: 10.1007/s11906-001-0040-8 PubMedGoogle Scholar
  25. 25.
    Hedner J et al (2006) Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J 27(3):564–570. doi: 10.1183/09031936.06.00042105 PubMedGoogle Scholar
  26. 26.
    Lugaresi E et al (1980) Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 3(3–4):221–224PubMedGoogle Scholar
  27. 27.
    Partinen M, Guilleminault C (1990) Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 97(1):27–32. doi: 10.1378/chest.97.1.27 PubMedGoogle Scholar
  28. 28.
    Davies CW et al (2000) Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 55(9):736–740. doi: 10.1136/thorax.55.9.736 PubMedGoogle Scholar
  29. 29.
    Suzuki M et al (1996) Blood pressure “dipping” and “non-dipping” in obstructive sleep apnea syndrome patients. Sleep 19(5):382–387PubMedGoogle Scholar
  30. 30.
    Baguet JP et al (2005) Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 23(3):521–527. doi: 10.1097/01.hjh.0000160207.58781.4e PubMedGoogle Scholar
  31. 31.
    Sharabi Y et al (2003) Diastolic blood pressure is the first to rise in association with early subclinical obstructive sleep apnea: lessons from periodic examination screening. Am J Hypertens 16(3):236–239. doi: 10.1016/S0895-7061(02)03250-8 PubMedGoogle Scholar
  32. 32.
    Grote L, Hedner J, Peter JH (2001) Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder. J Hypertens 19(4):683–690. doi: 10.1097/00004872-200104000-00004 PubMedGoogle Scholar
  33. 33.
    Haas DC et al (2005) Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 111(5):614–621. doi: 10.1161/01.CIR.0000154540.62381.CF PubMedGoogle Scholar
  34. 34.
    Sin DD et al (2003) Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 123(5):1536–1543. doi: 10.1378/chest.123.5.1536 PubMedGoogle Scholar
  35. 35.
    Hla KM et al (1994) Sleep apnea and hypertension. A population-based study. Ann Intern Med 120(5):382–388PubMedGoogle Scholar
  36. 36.
    Nieto FJ et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283(14):1829–1836. doi: 10.1001/jama.283.14.1829 PubMedGoogle Scholar
  37. 37.
    Brooks D et al (1997) Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99(1):106–109. doi: 10.1172/JCI119120 PubMedGoogle Scholar
  38. 38.
    Fletcher EC (2001) Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 90(4):1600–1605PubMedGoogle Scholar
  39. 39.
    Fletcher EC (2000) Cardiovascular consequences of obstructive sleep apnea: experimental hypoxia and sympathetic activity. Sleep 23(Suppl 4):S127–S131PubMedGoogle Scholar
  40. 40.
    Bao G et al (1997) Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83(1):95–101PubMedGoogle Scholar
  41. 41.
    Fletcher EC, Bao G (1996) The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep 19(10, Suppl):S210–S212PubMedGoogle Scholar
  42. 42.
    Xie A et al (2000) Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 89(4):1333–1339PubMedGoogle Scholar
  43. 43.
    Khayat RN et al (2003) Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest 123(5):1551–1560. doi: 10.1378/chest.123.5.1551 PubMedGoogle Scholar
  44. 44.
    Katragadda S et al (1997) Neural mechanism of the pressor response to obstructive and nonobstructive apnea. J Appl Physiol 83(6):2048–2054PubMedGoogle Scholar
  45. 45.
    Arabi Y et al (1999) Daytime blood pressure elevation after nocturnal hypoxia. J Appl Physiol 87(2):689–698PubMedGoogle Scholar
  46. 46.
    Logan AG et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277. doi: 10.1097/00004872-200112000-00022 PubMedGoogle Scholar
  47. 47.
    MacMahon S et al (1990) Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335(8692):765–774. doi: 10.1016/0140-6736(90)90878-9 PubMedGoogle Scholar
  48. 48.
    Pepperell JC et al (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359(9302):204–210. doi: 10.1016/S0140-6736(02)07445-7 PubMedGoogle Scholar
  49. 49.
    Campos-Rodriguez F et al (2007) Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 132(6):1847–1852. doi: 10.1378/chest.07-1478 PubMedGoogle Scholar
  50. 50.
    Robinson GV et al (2006) Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 27(6):1229–1235. doi: 10.1183/09031936.06.00062805 PubMedGoogle Scholar
  51. 51.
    Somers VK et al (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904. doi: 10.1172/JCI118235 PubMedGoogle Scholar
  52. 52.
    Adhikary G et al (2001) Gene regulation during intermittent hypoxia: evidence for the involvement of reactive oxygen species. Adv Exp Med Biol 499:297–302PubMedGoogle Scholar
  53. 53.
    Prabhakar NR et al (2001) Intermittent hypoxia: cell to system. Am J Physiol Lung Cell Mol Physiol 281(3):L524–L528PubMedGoogle Scholar
  54. 54.
    Xie A et al (2001) Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 91(4):1555–1562PubMedGoogle Scholar
  55. 55.
    Fletcher EC (1997) Sympathetic activity and blood pressure in the sleep apnea syndrome. Respiration 64(Suppl 1):22–28PubMedGoogle Scholar
  56. 56.
    Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27(1):123–128PubMedGoogle Scholar
  57. 57.
    Carpagnano GE et al (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124(4):1386–1392. doi: 10.1378/chest.124.4.1386 PubMedGoogle Scholar
  58. 58.
    Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285–1295PubMedGoogle Scholar
  59. 59.
    Prior JO et al (2005) Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 111(18):2291–2298. doi: 10.1161/01.CIR.0000164232.62768.51 PubMedGoogle Scholar
  60. 60.
    Bugiardini R et al (2004) Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109(21):2518–2523. doi: 10.1161/01.CIR.0000128208.22378.E3 PubMedGoogle Scholar
  61. 61.
    De Vriese AS et al (2004) Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation 109(19):2331–2336. doi: 10.1161/01.CIR.0000129138.08493.4D PubMedGoogle Scholar
  62. 62.
    MacCarthy PA, Shah AM (2000) Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 101(15):1854–1860PubMedGoogle Scholar
  63. 63.
    Grebe M et al (2006) Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173(8):897–901. doi: 10.1164/rccm.200508-1223OC PubMedGoogle Scholar
  64. 64.
    Bostrom KB et al (2007) Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 25(4):779–783PubMedGoogle Scholar
  65. 65.
    Moller DS et al (2003) Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16(4):274–280. doi: 10.1016/S0895-7061(02)03267-3 PubMedGoogle Scholar
  66. 66.
    Fletcher EC, Orolinova N, Bader M (2002) Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92(2):627–633PubMedGoogle Scholar
  67. 67.
    Fletcher EC, Bao G, Li R (1999) Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34(2):309–314PubMedGoogle Scholar
  68. 68.
    Rosamond W et al (2007) Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5):e69–e171. doi: 10.1161/CIRCULATIONAHA.106.179918 PubMedGoogle Scholar
  69. 69.
    Nieminen MS et al (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27(22):2725–2736. doi: 10.1093/eurheartj/ehl193 PubMedGoogle Scholar
  70. 70.
    Ip MS et al (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169(3):348–353. doi: 10.1164/rccm.200306-767OC PubMedGoogle Scholar
  71. 71.
    Schulz R et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162(2 Pt 1):566–570PubMedGoogle Scholar
  72. 72.
    Barcelo A et al (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16(4):644–647. doi: 10.1034/j.1399-3003.2000.16d13.x PubMedGoogle Scholar
  73. 73.
    Minoguchi K et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):625–630. doi: 10.1164/rccm.200412-1652OC PubMedGoogle Scholar
  74. 74.
    Sorajja D et al (2008) Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133(4):927–933PubMedGoogle Scholar
  75. 75.
    Hanly P et al (1993) ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71(15):1341–1345. doi: 10.1016/0002-9149(93)90552-N PubMedGoogle Scholar
  76. 76.
    Alonso-Fernandez A et al (2005) Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest 127(1):15–22. doi: 10.1378/chest.127.1.15 PubMedGoogle Scholar
  77. 77.
    Peled N et al (1999) Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 34(6):1744–1749. doi: 10.1016/S0735-1097(99)00407-6 PubMedGoogle Scholar
  78. 78.
    Peters RW (2005) Obstructive sleep apnea and cardiovascular disease. Chest 127(1):1–3. doi: 10.1378/chest.127.1.1 PubMedGoogle Scholar
  79. 79.
    Schafer H et al (1997) Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 111(2):387–393. doi: 10.1378/chest.111.2.387 PubMedGoogle Scholar
  80. 80.
    Beguin PC et al (2005) Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol 99(3):1064–1069. doi: 10.1152/japplphysiol.00056.2005 PubMedGoogle Scholar
  81. 81.
    Joyeux-Faure M et al (2005) Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 98(5):1691–1696. doi: 10.1152/japplphysiol.01146.2004 PubMedGoogle Scholar
  82. 82.
    Shahar E et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25PubMedGoogle Scholar
  83. 83.
    Peker Y et al (2000) Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162(1):81–86PubMedGoogle Scholar
  84. 84.
    Mooe T et al (2001) Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164(10 Pt 1):1910–1913PubMedGoogle Scholar
  85. 85.
    Yumino D et al (2007) Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 99(1):26–30. doi: 10.1016/j.amjcard.2006.07.055 PubMedGoogle Scholar
  86. 86.
    Milleron O et al (2004) Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25(9):728–734. doi: 10.1016/j.ehj.2004.02.008 PubMedGoogle Scholar
  87. 87.
    Javaheri S (2000) Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101(4):392–397PubMedGoogle Scholar
  88. 88.
    Mehra R et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 173(8):910–916. doi: 10.1164/rccm.200509-1442OC PubMedGoogle Scholar
  89. 89.
    Ryan CM et al (2005) Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60(9):781–785. doi: 10.1136/thx.2005.040972 PubMedGoogle Scholar
  90. 90.
    Gilman MP et al (2008) Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 114(3):243–249. doi: 10.1042/CS20070172 CrossRefGoogle Scholar
  91. 91.
    Gami AS et al (2007) Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49(5):565–571. doi: 10.1016/j.jacc.2006.08.060 PubMedGoogle Scholar
  92. 92.
    Gami AS et al (2005) Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352(12):1206–1214. doi: 10.1056/NEJMoa041832 PubMedGoogle Scholar
  93. 93.
    Yaggi HK et al (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041. doi: 10.1056/NEJMoa043104 PubMedGoogle Scholar
  94. 94.
    Mehra R, Benjamin EJ, Shahar E et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the sleep heart health study. Am J Respir Crit Care Med 173(8):910–916PubMedGoogle Scholar
  95. 95.
    Ferrier K et al (2005) Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 128(4):2116–2122. doi: 10.1378/chest.128.4.2116 PubMedGoogle Scholar
  96. 96.
    Javaheri S (2006) Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 106(1):21–28. doi: 10.1016/j.ijcard.2004.12.068 PubMedGoogle Scholar
  97. 97.
    Javaheri S et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMedGoogle Scholar
  98. 98.
    Mossey P, Singh GD, Smith ME (1999) More extensive analysis is needed when assessing facial structure in SIDS. BMJ (Clin Res Ed.) 318(7180):396–397Google Scholar
  99. 99.
    Sin DD et al (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1101–1106PubMedGoogle Scholar
  100. 100.
    Hedner J, Ejnell H, Caidahl K (1990) Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 8(10):941–946. doi: 10.1097/00004872-199010000-00009 PubMedGoogle Scholar
  101. 101.
    Laaban JP et al (2002) Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 122(4):1133–1138. doi: 10.1378/chest.122.4.1133 PubMedGoogle Scholar
  102. 102.
    Parker JD et al (1999) Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160(6):1888–1896PubMedGoogle Scholar
  103. 103.
    Tkacova R et al (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98(21):2269–2275PubMedGoogle Scholar
  104. 104.
    Chen L, Shi Q, Scharf SM (2000) Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol 88(3):1051–1060PubMedGoogle Scholar
  105. 105.
    Scharf SM, Graver LM, Balaban K (1992) Cardiovascular effects of periodic occlusions of the upper airways in dogs. Am Rev Respir Dis 146(2):321–329PubMedGoogle Scholar
  106. 106.
    Chen L, Scharf SM (1998) Systemic and myocardial hemodynamics during periodic obstructive apneas in sedated pigs. J Appl Physiol 84(4):1289–1298PubMedGoogle Scholar
  107. 107.
    Spaak J et al (2005) Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 46(6):1327–1332. doi: 10.1161/01.HYP.0000193497.45200.66 PubMedGoogle Scholar
  108. 108.
    Usui K et al (2005) Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45(12):2008–2011. doi: 10.1016/j.jacc.2004.12.080 PubMedGoogle Scholar
  109. 109.
    Malone S et al (1991) Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 338(8781):1480–1484. doi: 10.1016/0140-6736(91)92299-H PubMedGoogle Scholar
  110. 110.
    Mansfield DR, Naughton MT (2004) Sleep apnea and congestive heart failure. Minerva Med 95(4):257–280PubMedGoogle Scholar
  111. 111.
    Roebuck T et al (2004) Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 23(5):735–740. doi: 10.1183/09031936.04.00060404 PubMedGoogle Scholar
  112. 112.
    Bady E et al (2000) Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax 55(11):934–939. doi: 10.1136/thorax.55.11.934 PubMedGoogle Scholar
  113. 113.
    Sajkov D et al (1994) Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 149(2 Pt 1):416–422PubMedGoogle Scholar
  114. 114.
    Sanner BM et al (1997) Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 157(21):2483–2487. doi: 10.1001/archinte.157.21.2483 PubMedGoogle Scholar
  115. 115.
    Chaouat A et al (1996) Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 109(2):380–386. doi: 10.1378/chest.109.2.380 PubMedGoogle Scholar
  116. 116.
    Weitzenblum E et al (1988) Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138(2):345–349PubMedGoogle Scholar
  117. 117.
    Atwood CW Jr et al (2004) Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):72S–77S. doi: 10.1378/chest.126.1_suppl.72S PubMedGoogle Scholar
  118. 118.
    Gozal D, Lipton AJ, Jones KL (2002) Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25(1):59–65PubMedGoogle Scholar
  119. 119.
    Lavie L et al (2002) Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165(12):1624–1628. doi: 10.1164/rccm.20110-040OC PubMedGoogle Scholar
  120. 120.
    Berman EJ et al (1991) Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. Chest 100(2):347–350. doi: 10.1378/chest.100.2.347 PubMedGoogle Scholar
  121. 121.
    Sanner BM et al (1997) Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 10(9):2079–2083. doi: 10.1183/09031936.97.10092079 PubMedGoogle Scholar
  122. 122.
    Nahmias J, Lao R, Karetzky M (1996) Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure. Eur Respir J 9(5):945–951. doi: 10.1183/09031936.96.09050945 PubMedGoogle Scholar
  123. 123.
    Alchanatis M et al (2001) Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 68(6):566–572. doi: 10.1159/000050574 PubMedGoogle Scholar
  124. 124.
    Sajkov D et al (2002) Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 165(2):152–158PubMedGoogle Scholar
  125. 125.
    Bassetti CL, Milanova M, Gugger M (2006) Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 37(4):967–972. doi: 10.1161/01.STR.0000208215.49243.c3 PubMedGoogle Scholar
  126. 126.
    Foster GE et al (2007) Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. Am J Respir Crit Care Med 175(7):720–725. doi: 10.1164/rccm.200609-1271OC PubMedGoogle Scholar
  127. 127.
    Phillips SA et al (2004) Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286(1):H388–H393. doi: 10.1152/ajpheart.00683.2003 PubMedGoogle Scholar
  128. 128.
    Baguet JP et al (2005) The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128(5):3407–3412. doi: 10.1378/chest.128.5.3407 PubMedGoogle Scholar
  129. 129.
    Suzuki T et al (2004) Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 27(1):129–133PubMedGoogle Scholar
  130. 130.
    Drager LF et al (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712. doi: 10.1164/rccm.200703-500OC PubMedGoogle Scholar
  131. 131.
    Yaggi H, Mohsenin V (2004) Obstructive sleep apnoea and stroke. Lancet Neurol 3(6):333–342. doi: 10.1016/S1474-4422(04)00766-5 PubMedGoogle Scholar
  132. 132.
    Turkington PM, Elliott MW (2004) Sleep disordered breathing following stroke. Monaldi Arch Chest Dis 61(3):157–161PubMedGoogle Scholar
  133. 133.
    Parra O et al (2000) Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 161(2 Pt 1):375–380PubMedGoogle Scholar
  134. 134.
    Selic C et al (2005) Blood pressure evolution after acute ischemic stroke in patients with and without sleep apnea. Stroke 36(12):2614–2618. doi: 10.1161/01.STR.0000189689.65734.a3 PubMedGoogle Scholar
  135. 135.
    Parra O et al (2004) Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J 24(2):267–272. doi: 10.1183/09031936.04.00061503 PubMedGoogle Scholar
  136. 136.
    Martinez-Garcia MA et al (2005) Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 128(4):2123–2129. doi: 10.1378/chest.128.4.2123 PubMedGoogle Scholar
  137. 137.
    Dziewas R et al (2005) Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims. J Neurol 252(11):1394–1398. doi: 10.1007/s00415-005-0888-7 PubMedGoogle Scholar
  138. 138.
    Kaneko Y et al (2003) Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 26(3):293–297PubMedGoogle Scholar
  139. 139.
    Arzt M et al (2005) Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172(11):1447–1451. doi: 10.1164/rccm.200505-702OC PubMedGoogle Scholar
  140. 140.
    Good DC et al (1996) Sleep-disordered breathing and poor functional outcome after stroke. Stroke 27(2):252–259PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Kiran Devulapally
    • 1
  • Raymond PongonisJr.
    • 2
  • Rami Khayat
    • 1
    • 3
  1. 1.Division of Pulmonary, Critical Care, and Sleep MedicineOhio State UniversityColumbusUSA
  2. 2.Department of MedicineFeinberg School of Medicine, Northwestern UniversityChicagoUSA
  3. 3.The OSU Sleep-Heart ProgramOhio State UniversityColumbusUSA

Personalised recommendations